NYSE:CXS

(CXS) (CXS) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CXS stock logo

About (CXS) Stock (NYSE:CXS)

CreXus Investment Corp. is a real estate investment trust (REIT). The Company is a commercial real estate company that acquires, manages, and finances, directly or through its subsidiaries, commercial mortgage loans and other commercial real estate debt, commercial real property, commercial mortgage-backed securities (CMBS), other commercial real estate-related assets and Agency residential mortgage-backed securities. The Company also engages in long-term sale-leaseback and build-to-suit transactions with companies in the United States. The Company is managed by Fixed Income Discount Advisory Company (FIDAC). FIDAC is a wholly owned subsidiary of Annaly Capital Management, Inc. (Annaly).

CXS Stock News Headlines

These AI trades triggered this morning (545% return)
If you think a market crash is possible in 2024, I don't know why you're not using this yet.
ChallengerX Plc - Results of Annual General Meeting
The World's First "$20 Trillion Drug?"
One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!
ChallengerX Plc - Notice of Annual General Meeting
ChallengerX Plc - Board appointment
See More Headlines
Receive CXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CXS) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Kevin Riordan (Age 57)
    President, Chief Executive Officer, Director
  • Jack DeCicco (Age 41)
    Chief Financial Officer
  • Robert Restrick (Age 48)
    Chief Operating Officer
  • Jeffrey Conti (Age 54)
    Head - Commercial Underwriting
  • Robert M. Karner (Age 51)
    Global Head - Debt Investments
  • Patrick J. Corcoran (Age 66)
    Non-Executive Independent Chairman of the Board
  • Ronald D. Kazel (Age 45)
    Director
  • Robert B. Eastep CPA (Age 52)
    Independent Director
  • Nancy Jo Kuenstner (Age 59)
    Independent Director

CXS Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (CXS) own?
This page (NYSE:CXS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners